Chemical Compounds
Phthalimide
68%
Anti Myeloma
61%
Lenalidomide
49%
Thalidomide
42%
Pharmacokinetics
41%
Cytogenetics
38%
Peak Plasma Concentration
37%
Intraperitoneal
35%
Drug
28%
Reaction Half Life
26%
Fragmentation
22%
Acid
9%
Agriculture & Biology
phthalimide
90%
osteoclasts
75%
myeloma
69%
chemical derivatives
41%
cells
17%
pharmacokinetics
11%
apoptosis
11%
mice
10%
drugs
8%
chromosome translocation
8%
chromosome elimination
7%
prognosis
7%
intraperitoneal injection
6%
tubulin
6%
cytogenetics
6%
acid phosphatase
5%
half life
5%
bones
5%
lesions (animal)
4%
neoplasms
4%
injection
4%
Medicine & Life Sciences
phthalimide
100%
Osteoclasts
56%
Multiple Myeloma
54%
Chromosome 17 deletion
14%
Pharmacokinetics
11%
nucleophosmin
11%
Lenalidomide
10%
Tartrate-Resistant Acid Phosphatase
10%
Thalidomide
9%
Apoptosis
9%
Macrophage Colony-Stimulating Factor
9%
SCID Mice
9%
Tubulin
8%
Cytogenetics
7%
Intraperitoneal Injections
7%
Half-Life
6%
Pharmaceutical Preparations
6%
Bone and Bones
4%
Injections
4%
Growth
3%
In Vitro Techniques
3%
Neoplasms
2%
Therapeutics
1%